Mature oligodendrocytes bordering lesions limit demyelination and favor myelin repair via heparan sulfate production.


Journal

eLife
ISSN: 2050-084X
Titre abrégé: Elife
Pays: England
ID NLM: 101579614

Informations de publication

Date de publication:
09 06 2020
Historique:
received: 17 09 2019
accepted: 09 06 2020
pubmed: 10 6 2020
medline: 4 3 2021
entrez: 10 6 2020
Statut: epublish

Résumé

Myelin destruction is followed by resident glia activation and mobilization of endogenous progenitors (OPC) which participate in myelin repair. Here we show that in response to demyelination, mature oligodendrocytes (OLG) bordering the lesion express Ndst1, a key enzyme for heparan sulfates (HS) synthesis. Ndst1+ OLG form a belt that demarcates lesioned from intact white matter. Mice with selective inactivation of Ndst1 in the OLG lineage display increased lesion size, sustained microglia and OPC reactivity. HS production around the lesion allows Sonic hedgehog (Shh) binding and favors the local enrichment of this morphogen involved in myelin regeneration. In MS patients, Ndst1 is also found overexpressed in oligodendroglia and the number of Ndst1-expressing oligodendroglia is inversely correlated with lesion size and positively correlated with remyelination potential. Our study suggests that mature OLG surrounding demyelinated lesions are not passive witnesses but contribute to protection and regeneration by producing HS.

Identifiants

pubmed: 32515730
doi: 10.7554/eLife.51735
pii: 51735
pmc: PMC7308090
doi:
pii:

Substances chimiques

Hedgehog Proteins 0
Lysophosphatidylcholines 0
Shh protein, mouse 0
Heparitin Sulfate 9050-30-0
Sulfotransferases EC 2.8.2.-
heparitin sulfotransferase EC 2.8.2.8

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Medical Research Council
ID : MR/K017047/1
Pays : United Kingdom
Organisme : Agence Nationale de la Recherche
ID : ANR-15-CE16-0014-01
Pays : International
Organisme : AM*DEX NeuroMarseille Institute
ID : AMX-19-IET-004
Pays : International
Organisme : Fondation pour la Recherche Médicale
ID : DEQ20140329501
Pays : International

Informations de copyright

© 2020, Macchi et al.

Déclaration de conflit d'intérêts

MM, KM, CZ, EP, BE, BB, SJ, KG, FK, AW, MC, PD No competing interests declared

Références

J Biol Chem. 2012 Dec 21;287(52):43708-19
pubmed: 23118222
Glia. 2006 Feb;53(3):294-303
pubmed: 16265670
J Clin Invest. 2001 Aug;108(3):357-61
pubmed: 11489926
Glia. 2012 Feb;60(2):306-21
pubmed: 22072381
Nature. 2000 Apr 13;404(6779):725-8
pubmed: 10783877
Acta Neuropathol Commun. 2018 Jan 4;6(1):4
pubmed: 29301568
Nat Neurosci. 2007 Aug;10(8):990-1002
pubmed: 17618276
Nature. 2007 Nov 29;450(7170):717-20
pubmed: 18046410
J Cell Sci. 2015 Jun 15;128(12):2374-85
pubmed: 25967551
Glia. 2015 Oct;63(10):1714-28
pubmed: 25913734
Brain Res Bull. 2002 Apr;57(6):827-32
pubmed: 12031280
Brain Behav Immun. 2017 Jul;63:197-209
pubmed: 27818218
J Biol Chem. 2008 Jun 13;283(24):16885-94
pubmed: 18385133
J Neurosci. 2013 Feb 13;33(7):3240-50
pubmed: 23407977
J Biol Chem. 1998 Sep 25;273(39):24979-82
pubmed: 9737951
Nat Commun. 2016 Apr 26;7:11312
pubmed: 27115988
Brain. 2006 Dec;129(Pt 12):3165-72
pubmed: 16921173
Exp Neurol. 2013 Sep;247:113-21
pubmed: 23588220
Dev Dyn. 2007 Feb;236(2):556-63
pubmed: 17183530
Adv Exp Med Biol. 1997;429:69-77
pubmed: 9413566
J Neurosci. 2013 Jan 30;33(5):1759-72
pubmed: 23365216
Glia. 2002 Jul;39(1):1-9
pubmed: 12112370
Nat Neurosci. 2013 Sep;16(9):1211-1218
pubmed: 23872599
Immunology. 2014 Mar;141(3):302-13
pubmed: 23981039
J Cell Biochem. 2005 Nov 1;96(4):831-8
pubmed: 16149075
J Neurochem. 2011 Oct;119(1):176-88
pubmed: 21848846
J Cell Biol. 1992 Nov;119(4):961-75
pubmed: 1385449
Nature. 2019 Feb;566(7745):543-547
pubmed: 30747918
Nature. 2019 Feb;566(7745):538-542
pubmed: 30675058
Gene Ther. 2001 Aug;8(16):1207-13
pubmed: 11509953
Philos Trans R Soc Lond B Biol Sci. 2014 Dec 5;369(1657):
pubmed: 25349453
Nat Rev Mol Cell Biol. 2005 Jul;6(7):530-41
pubmed: 16072037
Exp Neurol. 2015 Jul;269:213-23
pubmed: 25862289
Nat Rev Neurosci. 2008 Nov;9(11):839-55
pubmed: 18931697
J Neurosci Res. 1992 Sep;33(1):47-59
pubmed: 1280690
PLoS One. 2011;6(5):e20430
pubmed: 21647369
Glia. 2003 Apr 15;42(2):130-8
pubmed: 12655597
PLoS One. 2011;6(7):e22623
pubmed: 21818353
N Engl J Med. 2002 Jan 17;346(3):165-73
pubmed: 11796850
Dev Neurosci. 2001;23(4-5):318-26
pubmed: 11756747
Mult Scler. 2009 May;15(5):531-41
pubmed: 19389748
Muscle Nerve. 2002 Nov;26(5):713-5
pubmed: 12402295
Glia. 2016 Feb;64(2):270-86
pubmed: 26454153
Brain. 2007 Oct;130(Pt 10):2554-65
pubmed: 17855378
J Neurosci. 2002 Oct 1;22(19):8574-85
pubmed: 12351731
J Neurosci Res. 1997 Oct 15;50(2):190-201
pubmed: 9373029
Development. 2005 Aug;132(16):3777-86
pubmed: 16020517
Science. 2010 Nov 5;330(6005):779-82
pubmed: 21051629
Mol Cell Neurosci. 1999 Aug;14(2):153-68
pubmed: 10532806
Stem Cell Reports. 2019 Jun 11;12(6):1223-1231
pubmed: 31189094
ACS Chem Biol. 2010 Jan 15;5(1):35-46
pubmed: 19968325
Prog Brain Res. 2014;214:353-88
pubmed: 25410365
J Biol Chem. 2008 Jul 18;283(29):20008-14
pubmed: 18487608
Development. 2013 Aug;140(15):3107-17
pubmed: 23824572
Cold Spring Harb Perspect Biol. 2011 Jul 01;3(7):
pubmed: 21690215
Proc Natl Acad Sci U S A. 2018 Dec 11;115(50):E11807-E11816
pubmed: 30487224
Nat Neurosci. 2019 Jul;22(7):1046-1052
pubmed: 31182869
J Mol Neurosci. 2012 Sep;48(1):77-85
pubmed: 22552714
Neurobiol Dis. 2012 Jan;45(1):196-205
pubmed: 21854849
Development. 2019 May 2;146(9):
pubmed: 31048318
Eur J Neurosci. 2007 Feb;25(3):761-71
pubmed: 17298600
Acta Neuropathol. 2013 Jun;125(6):841-59
pubmed: 23595275
Development. 2002 May;129(9):2223-32
pubmed: 11959830
Neuron. 1990 Nov;5(5):603-14
pubmed: 2171589
Matrix Biol. 2014 Apr;35:253-65
pubmed: 24200809
Neurochem Res. 2007 Apr-May;32(4-5):783-97
pubmed: 17186374
Ann Neurol. 2012 Sep;72(3):419-32
pubmed: 23034914
Front Neurosci. 2014 Jun 12;8:145
pubmed: 24971048
Prog Brain Res. 1998;117:233-47
pubmed: 9932412
Int J Dev Biol. 2005;49(2-3):209-20
pubmed: 15906234
Neurobiol Dis. 2006 Dec;24(3):484-91
pubmed: 17005408

Auteurs

Magali Macchi (M)

Aix Marseille Univ, CNRS, IBDM, Marseille, France.

Karine Magalon (K)

Aix Marseille Univ, CNRS, IBDM, Marseille, France.

Céline Zimmer (C)

Aix Marseille Univ, CNRS, IBDM, Marseille, France.

Elitsa Peeva (E)

MRC Centre for Regenerative Medicine, Multiple Sclerosis Society Centre for Translational Research, University of Edinburgh, Edinburgh, United Kingdom.

Bilal El Waly (B)

Aix Marseille Univ, CNRS, IBDM, Marseille, France.

Béatrice Brousse (B)

Aix Marseille Univ, CNRS, IBDM, Marseille, France.

Sarah Jaekel (S)

MRC Centre for Regenerative Medicine, Multiple Sclerosis Society Centre for Translational Research, University of Edinburgh, Edinburgh, United Kingdom.

Kay Grobe (K)

Institute of Physiological Chemistry and Pathobiochemistry and Cells-in-Motion Cluster of Excellence (EXC1003-CiM), University of Münster, Münster, Germany.

Friedemann Kiefer (F)

Max Planck Institute for Molecular Biomedicine, Münster, Germany.

Anna Williams (A)

MRC Centre for Regenerative Medicine, Multiple Sclerosis Society Centre for Translational Research, University of Edinburgh, Edinburgh, United Kingdom.

Myriam Cayre (M)

Aix Marseille Univ, CNRS, IBDM, Marseille, France.

Pascale Durbec (P)

Aix Marseille Univ, CNRS, IBDM, Marseille, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH